129 related articles for article (PubMed ID: 10555653)
1. Brain morphometric analysis in neurofibromatosis 1.
DiMario FJ; Ramsby GR; Burleson JA
Arch Neurol; 1999 Nov; 56(11):1343-6. PubMed ID: 10555653
[TBL] [Abstract][Full Text] [Related]
2. Brain morphometric analysis in achondroplasia.
DiMario FJ; Ramsby GR; Burleson JA; Greensheilds IR
Neurology; 1995 Mar; 45(3 Pt 1):519-24. PubMed ID: 7898709
[TBL] [Abstract][Full Text] [Related]
3. Learning disabilities in neurofibromatosis 1: sizing up the brain.
Gutmann DH
Arch Neurol; 1999 Nov; 56(11):1322-3. PubMed ID: 10555648
[No Abstract] [Full Text] [Related]
4. Brain morphometry, T2-weighted hyperintensities, and IQ in children with neurofibromatosis type 1.
Greenwood RS; Tupler LA; Whitt JK; Buu A; Dombeck CB; Harp AG; Payne ME; Eastwood JD; Krishnan KR; MacFall JR
Arch Neurol; 2005 Dec; 62(12):1904-8. PubMed ID: 16344348
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis.
Moore BD; Slopis JM; Schomer D; Jackson EF; Levy BM
Neurology; 1996 Jun; 46(6):1660-8. PubMed ID: 8649566
[TBL] [Abstract][Full Text] [Related]
6. Examining the frontal subcortical brain vulnerability hypothesis in children with neurofibromatosis type 1: Are T2-weighted hyperintensities related to executive dysfunction?
Roy A; Barbarot S; Charbonnier V; Gayet-Delacroix M; Stalder JF; Roulin JL; Le Gall D
Neuropsychology; 2015 May; 29(3):473-84. PubMed ID: 25365565
[TBL] [Abstract][Full Text] [Related]
7. Is magnetic resonance spectroscopy capable of detecting metabolic abnormalities in neurofibromatosis type 1 that are not revealed in brain parenchyma of normal appearance?
Rodrigues AC; Ferraz-Filho JR; Torres US; da Rocha AJ; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino ÉC
Pediatr Neurol; 2015 Mar; 52(3):314-9. PubMed ID: 25585912
[TBL] [Abstract][Full Text] [Related]
8. Cognitive profiles of neurofibromatosis type 1 patients with minor brain malformations.
Acosta MT; Walsh KS; Kardel PG; Kutteruf RE; Bhatt RR; Bouton TC; Vezina LG; Packer RJ
Pediatr Neurol; 2012 Apr; 46(4):231-4. PubMed ID: 22490768
[TBL] [Abstract][Full Text] [Related]
9. Are morphological and structural MRI characteristics related to specific cognitive impairments in neurofibromatosis type 1 (NF1) children?
Baudou E; Nemmi F; Biotteau M; Maziero S; Assaiante C; Cignetti F; Vaugoyeau M; Audic F; Peran P; Chaix Y
Eur J Paediatr Neurol; 2020 Sep; 28():89-100. PubMed ID: 32893091
[TBL] [Abstract][Full Text] [Related]
10. MRI abnormalities in neurofibromatosis type 1 (NF1): a study of men and mice.
Rosenbaum T; Engelbrecht V; Krölls W; van Dorsten FA; Hoehn-Berlage M; Lenard HG
Brain Dev; 1999 Jun; 21(4):268-73. PubMed ID: 10392751
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging lesion analysis in neurofibromatosis type 1.
DiMario FJ; Ramsby G
Arch Neurol; 1998 Apr; 55(4):500-5. PubMed ID: 9561977
[TBL] [Abstract][Full Text] [Related]
12. Neurofibromatosis type 1: motor and cognitive function and T2-weighted MRI hyperintensities.
Feldmann R; Denecke J; Grenzebach M; Schuierer G; Weglage J
Neurology; 2003 Dec; 61(12):1725-8. PubMed ID: 14694037
[TBL] [Abstract][Full Text] [Related]
13. Neurofibromatosis type 1 growth charts.
Clementi M; Milani S; Mammi I; Boni S; Monciotti C; Tenconi R
Am J Med Genet; 1999 Dec; 87(4):317-23. PubMed ID: 10588837
[TBL] [Abstract][Full Text] [Related]
14. Sex differences in outcome and associations with neonatal brain morphology in extremely preterm children.
Skiöld B; Alexandrou G; Padilla N; Blennow M; Vollmer B; Adén U
J Pediatr; 2014 May; 164(5):1012-8. PubMed ID: 24530122
[TBL] [Abstract][Full Text] [Related]
15. Neurofibromatosis bright objects in children with neurofibromatosis type 1: a proliferative potential?
Griffiths PD; Blaser S; Mukonoweshuro W; Armstrong D; Milo-Mason G; Cheung S
Pediatrics; 1999 Oct; 104(4):e49. PubMed ID: 10506274
[TBL] [Abstract][Full Text] [Related]
16. Functional Connectivity Changes and Executive and Social Problems in Neurofibromatosis Type I.
Loitfelder M; Huijbregts SC; Veer IM; Swaab HS; Van Buchem MA; Schmidt R; Rombouts SA
Brain Connect; 2015 Jun; 5(5):312-20. PubMed ID: 25705926
[TBL] [Abstract][Full Text] [Related]
17. Quantitative microstructural cerebral changes in neurofibromatosis type 1.
Bültmann E; Spineli LM; Hartmann H; Sander A; Lanfermann H
Brain Dev; 2018 May; 40(5):376-382. PubMed ID: 29373161
[TBL] [Abstract][Full Text] [Related]
18. Abnormal Morphology of Select Cortical and Subcortical Regions in Neurofibromatosis Type 1.
Barkovich MJ; Tan CH; Nillo RM; Li Y; Xu D; Glastonbury CM; Glenn OA; Dillon WP; Hess CP; Mueller S; Kline C; Dale AM; Jernigan TL; Sugrue LP; Barkovich AJ; Desikan RS
Radiology; 2018 Nov; 289(2):499-508. PubMed ID: 30179114
[TBL] [Abstract][Full Text] [Related]
19. The role of unidentified bright objects in the neurocognitive profile of neurofibromatosis type 1 children: a volumetric MRI analysis.
Di Stasi M; Cocozza S; Buccino S; Paolella C; Di Napoli L; D'Amico A; Melis D; Ugga L; Villano G; Ruocco M; Scala I; Brunetti A; Elefante A
Acta Neurol Belg; 2024 Feb; 124(1):223-230. PubMed ID: 37733157
[TBL] [Abstract][Full Text] [Related]
20. Clinical sensitivity and specificity of multiple T2-hyperintensities on brain magnetic resonance imaging in diagnosis of neurofibromatosis type 1 in children: diagnostic accuracy study.
Sabol Z; Resić B; Gjergja Juraski R; Sabol F; Kovac Sizgorić M; Orsolić K; Ozretić D; Sepić-Grahovac D
Croat Med J; 2011 Aug; 52(4):488-96. PubMed ID: 21853543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
